Open access

Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements

Michael Charles Allwood, Donata Stonkute, Andrew Wallace, Alan-Shaun Wilkinson, Tim Hills, Conor Jamieson, on behalf of the BSAC Drug Stability Working Party, Mark Gilchrist, Mark Santillo, Andrew Seaton

10.1136/ejhpharm-2018-001515

September 18, 2018

Mixed methods study of medication-related decision support alerts experienced during electronic prescribing for inpatients at an English hospital

Helen Bell, Sara Garfield, Sonia Khosla, Chimnay Patel, Bryony Dean Franklin

10.1136/ejhpharm-2017-001483

May 19, 2018

Limited effect of structured medication report as the only intervention at discharge from hospital

Hanne Holdhus, Katrine Bøvre, Liv Mathiesen, Börje Bjelke, Kathrin Bjerknes

10.1136/ejhpharm-2017-001371

January 20, 2018

Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors

Israa Fadhil Yaseen, Hasan Ali Farhan, Hassan Mohamed Abbas

10.1136/ejhpharm-2017-001359

November 18, 2017

Pharmacotherapy within a learning healthcare system: rationale for the Dutch Santeon Farmadatabase

Ewoudt M W van de Garde, Bram C Plouvier, Hanneke W H A Fleuren, Eric A F Haak, Kris L L Movig, Maarten J Deenen, Marinus van Hulst

10.1136/ejhpharm-2017-001329

September 18, 2017

Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?

L Price, A M Brunt

10.1136/ejhpharm-2016-001155

March 16, 2017

Periprocedural management of patients receiving novel oral anticoagulants

Paloma Arias Pou, Aquerreta González, Luis José Prieto Martínez, Amaya Delgado Latorre, María Serrano Alonso

10.1136/ejhpharm-2016-001088

February 23, 2017

Value or cost: looking for the wider perspective

Phil Wiffen

10.1136/ejhpharm-2017-001213

February 22, 2017

Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?

Josefien Knoeff, Beat Flühmann, Stefan Mühlebach

10.1136/ejhpharm-2016-001059

January 23, 2017

Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab)

Jihyun Kim, Jihyun Chung, Sujin Park, Saem Jung, Dukwon Kang

10.1136/ejhpharm-2016-001085

January 13, 2017